MEGHAN MONK: Open Payments
NPI 1205491040 · MARLBOROUGH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 56 payments from 10 companies in 2025. Trend: 2023 $1,698 · 2024 $1,661 · 2025 $1,567
Food & beverage: $1,385Education: $182
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $450 |
| Janssen Biotech, Inc. | 11 | $374 |
| ABBVIE INC. | 13 | $250 |
| Lilly USA, LLC | 15 | $214 |
| Galderma Laboratories, L.P. | 2 | $105 |
| Amgen Inc. | 3 | $82 |
| LNHC, Inc | 2 | $37 |
| PFIZER INC. | 1 | $20 |
| Organon LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: Bimzelx, TREMFYA, RINVOQ, EBGLYSS, NEMLUVIO, SKYRIZI, TALTZ, Otezla.
Industry payments across MA — which companies pay providers there.
